nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—Cytochrome P450 3A4 Inducers—Amprenavir—acquired immunodeficiency syndrome	0.365	0.534	CiPCiCtD
Topiramate—Cytochrome P450 2C19 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.318	0.466	CiPCiCtD
Topiramate—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0145	0.0923	CbGbCtD
Topiramate—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0136	0.0868	CbGbCtD
Topiramate—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0123	0.0785	CbGbCtD
Topiramate—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0123	0.0785	CbGbCtD
Topiramate—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0106	0.0678	CbGbCtD
Topiramate—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0103	0.0658	CbGbCtD
Topiramate—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00933	0.0595	CbGbCtD
Topiramate—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00933	0.0595	CbGbCtD
Topiramate—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00895	0.057	CbGbCtD
Topiramate—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.007	0.0446	CbGbCtD
Topiramate—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00658	0.042	CbGbCtD
Topiramate—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00658	0.042	CbGbCtD
Topiramate—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00595	0.038	CbGbCtD
Topiramate—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00595	0.038	CbGbCtD
Topiramate—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00514	0.0328	CbGbCtD
Topiramate—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00499	0.0318	CbGbCtD
Topiramate—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00451	0.0288	CbGbCtD
Topiramate—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00451	0.0288	CbGbCtD
Topiramate—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00432	0.0276	CbGbCtD
Topiramate—GRIA4—nerve—acquired immunodeficiency syndrome	0.00275	0.0577	CbGeAlD
Topiramate—GRIK1—nerve—acquired immunodeficiency syndrome	0.00241	0.0506	CbGeAlD
Topiramate—GRIA3—nerve—acquired immunodeficiency syndrome	0.00224	0.047	CbGeAlD
Topiramate—CA6—saliva—acquired immunodeficiency syndrome	0.00208	0.0436	CbGeAlD
Topiramate—GRIA1—nerve—acquired immunodeficiency syndrome	0.0012	0.0251	CbGeAlD
Topiramate—GRIA4—retina—acquired immunodeficiency syndrome	0.00114	0.0239	CbGeAlD
Topiramate—GRIK3—retina—acquired immunodeficiency syndrome	0.00105	0.0221	CbGeAlD
Topiramate—GRIK1—retina—acquired immunodeficiency syndrome	0.000997	0.021	CbGeAlD
Topiramate—GRIK2—nerve—acquired immunodeficiency syndrome	0.000858	0.018	CbGeAlD
Topiramate—GRIK4—nervous system—acquired immunodeficiency syndrome	0.000781	0.0164	CbGeAlD
Topiramate—GRIK4—central nervous system—acquired immunodeficiency syndrome	0.000752	0.0158	CbGeAlD
Topiramate—GRIA4—spinal cord—acquired immunodeficiency syndrome	0.000733	0.0154	CbGeAlD
Topiramate—GRIK5—spinal cord—acquired immunodeficiency syndrome	0.000676	0.0142	CbGeAlD
Topiramate—GRIK3—spinal cord—acquired immunodeficiency syndrome	0.000676	0.0142	CbGeAlD
Topiramate—GRIK3—vagina—acquired immunodeficiency syndrome	0.000651	0.0137	CbGeAlD
Topiramate—GRIK1—spinal cord—acquired immunodeficiency syndrome	0.000643	0.0135	CbGeAlD
Topiramate—CA1—nerve—acquired immunodeficiency syndrome	0.000635	0.0133	CbGeAlD
Topiramate—GRIK1—vagina—acquired immunodeficiency syndrome	0.000618	0.013	CbGeAlD
Topiramate—GRIA4—nervous system—acquired immunodeficiency syndrome	0.000618	0.013	CbGeAlD
Topiramate—GRIA3—spinal cord—acquired immunodeficiency syndrome	0.000598	0.0126	CbGeAlD
Topiramate—GRIK4—brain—acquired immunodeficiency syndrome	0.000597	0.0125	CbGeAlD
Topiramate—GRIA4—central nervous system—acquired immunodeficiency syndrome	0.000595	0.0125	CbGeAlD
Topiramate—GRIK5—nervous system—acquired immunodeficiency syndrome	0.00057	0.012	CbGeAlD
Topiramate—GRIK3—nervous system—acquired immunodeficiency syndrome	0.00057	0.012	CbGeAlD
Topiramate—GRIK5—central nervous system—acquired immunodeficiency syndrome	0.000549	0.0115	CbGeAlD
Topiramate—GRIK3—central nervous system—acquired immunodeficiency syndrome	0.000549	0.0115	CbGeAlD
Topiramate—GRIK1—nervous system—acquired immunodeficiency syndrome	0.000542	0.0114	CbGeAlD
Topiramate—GRIK1—central nervous system—acquired immunodeficiency syndrome	0.000521	0.011	CbGeAlD
Topiramate—GRIA3—nervous system—acquired immunodeficiency syndrome	0.000503	0.0106	CbGeAlD
Topiramate—CA4—nerve—acquired immunodeficiency syndrome	0.000496	0.0104	CbGeAlD
Topiramate—GRIA1—retina—acquired immunodeficiency syndrome	0.000495	0.0104	CbGeAlD
Topiramate—GRIA3—central nervous system—acquired immunodeficiency syndrome	0.000485	0.0102	CbGeAlD
Topiramate—CA1—blood plasma—acquired immunodeficiency syndrome	0.00048	0.0101	CbGeAlD
Topiramate—GRIA4—brain—acquired immunodeficiency syndrome	0.000472	0.00992	CbGeAlD
Topiramate—GRIK3—brain—acquired immunodeficiency syndrome	0.000436	0.00915	CbGeAlD
Topiramate—GRIK5—brain—acquired immunodeficiency syndrome	0.000436	0.00915	CbGeAlD
Topiramate—GRIK5—lymph node—acquired immunodeficiency syndrome	0.000421	0.00885	CbGeAlD
Topiramate—GRIK3—lymph node—acquired immunodeficiency syndrome	0.000421	0.00885	CbGeAlD
Topiramate—GRIK1—brain—acquired immunodeficiency syndrome	0.000414	0.0087	CbGeAlD
Topiramate—GRIA3—brain—acquired immunodeficiency syndrome	0.000385	0.00809	CbGeAlD
Topiramate—CA7—digestive system—acquired immunodeficiency syndrome	0.000359	0.00754	CbGeAlD
Topiramate—GRIK2—retina—acquired immunodeficiency syndrome	0.000355	0.00747	CbGeAlD
Topiramate—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00034	0.00714	CbGeAlD
Topiramate—GRIA1—spinal cord—acquired immunodeficiency syndrome	0.000319	0.0067	CbGeAlD
Topiramate—CA9—digestive system—acquired immunodeficiency syndrome	0.000315	0.00662	CbGeAlD
Topiramate—CA2—blood plasma—acquired immunodeficiency syndrome	0.000311	0.00654	CbGeAlD
Topiramate—GRIA1—lung—acquired immunodeficiency syndrome	0.00029	0.0061	CbGeAlD
Topiramate—GRIA1—nervous system—acquired immunodeficiency syndrome	0.000269	0.00565	CbGeAlD
Topiramate—GRIA1—central nervous system—acquired immunodeficiency syndrome	0.000259	0.00544	CbGeAlD
Topiramate—GRIA2—spinal cord—acquired immunodeficiency syndrome	0.000253	0.00533	CbGeAlD
Topiramate—CA12—digestive system—acquired immunodeficiency syndrome	0.000233	0.0049	CbGeAlD
Topiramate—SCN1A—spinal cord—acquired immunodeficiency syndrome	0.000231	0.00486	CbGeAlD
Topiramate—GRIK2—spinal cord—acquired immunodeficiency syndrome	0.000229	0.00481	CbGeAlD
Topiramate—GRIA2—nervous system—acquired immunodeficiency syndrome	0.000214	0.00449	CbGeAlD
Topiramate—CA7—brain—acquired immunodeficiency syndrome	0.000212	0.00446	CbGeAlD
Topiramate—SCN1A—lung—acquired immunodeficiency syndrome	0.00021	0.00442	CbGeAlD
Topiramate—GRIA2—central nervous system—acquired immunodeficiency syndrome	0.000206	0.00432	CbGeAlD
Topiramate—GRIA1—brain—acquired immunodeficiency syndrome	0.000205	0.00432	CbGeAlD
Topiramate—SCN5A—digestive system—acquired immunodeficiency syndrome	0.000203	0.00426	CbGeAlD
Topiramate—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000201	0.00422	CbGeAlD
Topiramate—CA5B—blood—acquired immunodeficiency syndrome	0.000199	0.00419	CbGeAlD
Topiramate—SCN1A—nervous system—acquired immunodeficiency syndrome	0.000195	0.00409	CbGeAlD
Topiramate—CA12—lung—acquired immunodeficiency syndrome	0.000195	0.00409	CbGeAlD
Topiramate—SCN5A—blood—acquired immunodeficiency syndrome	0.000193	0.00406	CbGeAlD
Topiramate—GRIK2—nervous system—acquired immunodeficiency syndrome	0.000193	0.00405	CbGeAlD
Topiramate—SCN1A—central nervous system—acquired immunodeficiency syndrome	0.000188	0.00394	CbGeAlD
Topiramate—CA1—lymphoid tissue—acquired immunodeficiency syndrome	0.000187	0.00393	CbGeAlD
Topiramate—GRIK2—central nervous system—acquired immunodeficiency syndrome	0.000186	0.0039	CbGeAlD
Topiramate—CA1—digestive system—acquired immunodeficiency syndrome	0.000185	0.00388	CbGeAlD
Topiramate—CA5B—vagina—acquired immunodeficiency syndrome	0.000185	0.00388	CbGeAlD
Topiramate—CA12—nervous system—acquired immunodeficiency syndrome	0.00018	0.00379	CbGeAlD
Topiramate—GABRB2—spinal cord—acquired immunodeficiency syndrome	0.00018	0.00379	CbGeAlD
Topiramate—GABRG2—spinal cord—acquired immunodeficiency syndrome	0.00018	0.00379	CbGeAlD
Topiramate—SCN5A—vagina—acquired immunodeficiency syndrome	0.000179	0.00376	CbGeAlD
Topiramate—CA1—blood—acquired immunodeficiency syndrome	0.000176	0.0037	CbGeAlD
Topiramate—CA5B—lung—acquired immunodeficiency syndrome	0.000175	0.00367	CbGeAlD
Topiramate—CA12—central nervous system—acquired immunodeficiency syndrome	0.000174	0.00365	CbGeAlD
Topiramate—CA2—retina—acquired immunodeficiency syndrome	0.00017	0.00358	CbGeAlD
Topiramate—CA1—bone marrow—acquired immunodeficiency syndrome	0.00017	0.00358	CbGeAlD
Topiramate—CA1—spinal cord—acquired immunodeficiency syndrome	0.000169	0.00356	CbGeAlD
Topiramate—GABRB2—lung—acquired immunodeficiency syndrome	0.000164	0.00345	CbGeAlD
Topiramate—GRIA2—brain—acquired immunodeficiency syndrome	0.000163	0.00343	CbGeAlD
Topiramate—CA5B—nervous system—acquired immunodeficiency syndrome	0.000162	0.0034	CbGeAlD
Topiramate—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.000159	0.00334	CbGeAlD
Topiramate—SCN5A—nervous system—acquired immunodeficiency syndrome	0.000157	0.00329	CbGeAlD
Topiramate—CA5B—central nervous system—acquired immunodeficiency syndrome	0.000156	0.00327	CbGeAlD
Topiramate—CA1—lung—acquired immunodeficiency syndrome	0.000154	0.00324	CbGeAlD
Topiramate—GABRB2—nervous system—acquired immunodeficiency syndrome	0.000152	0.00319	CbGeAlD
Topiramate—GABRG2—nervous system—acquired immunodeficiency syndrome	0.000152	0.00319	CbGeAlD
Topiramate—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000151	0.00317	CbGeAlD
Topiramate—CA2—skin of body—acquired immunodeficiency syndrome	0.00015	0.00314	CbGeAlD
Topiramate—SCN1A—brain—acquired immunodeficiency syndrome	0.000149	0.00313	CbGeAlD
Topiramate—GRIK2—brain—acquired immunodeficiency syndrome	0.000147	0.0031	CbGeAlD
Topiramate—GABRB2—central nervous system—acquired immunodeficiency syndrome	0.000146	0.00307	CbGeAlD
Topiramate—GABRG2—central nervous system—acquired immunodeficiency syndrome	0.000146	0.00307	CbGeAlD
Topiramate—CA4—digestive system—acquired immunodeficiency syndrome	0.000144	0.00303	CbGeAlD
Topiramate—CA1—nervous system—acquired immunodeficiency syndrome	0.000143	0.003	CbGeAlD
Topiramate—CA12—brain—acquired immunodeficiency syndrome	0.000138	0.0029	CbGeAlD
Topiramate—CA4—blood—acquired immunodeficiency syndrome	0.000138	0.00289	CbGeAlD
Topiramate—CA1—central nervous system—acquired immunodeficiency syndrome	0.000138	0.00289	CbGeAlD
Topiramate—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000134	0.00282	CbGeAlD
Topiramate—CA4—bone marrow—acquired immunodeficiency syndrome	0.000133	0.0028	CbGeAlD
Topiramate—CA4—spinal cord—acquired immunodeficiency syndrome	0.000132	0.00278	CbGeAlD
Topiramate—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000131	0.00274	CbGeAlD
Topiramate—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.000129	0.00271	CbGeAlD
Topiramate—CYP2C19—blood—acquired immunodeficiency syndrome	0.000124	0.00261	CbGeAlD
Topiramate—CA5B—brain—acquired immunodeficiency syndrome	0.000124	0.0026	CbGeAlD
Topiramate—CA2—lymphoid tissue—acquired immunodeficiency syndrome	0.000121	0.00255	CbGeAlD
Topiramate—CA4—lung—acquired immunodeficiency syndrome	0.000121	0.00253	CbGeAlD
Topiramate—SCN5A—brain—acquired immunodeficiency syndrome	0.00012	0.00252	CbGeAlD
Topiramate—CA2—digestive system—acquired immunodeficiency syndrome	0.00012	0.00251	CbGeAlD
Topiramate—CA5B—lymph node—acquired immunodeficiency syndrome	0.000119	0.00251	CbGeAlD
Topiramate—GABRB2—brain—acquired immunodeficiency syndrome	0.000116	0.00244	CbGeAlD
Topiramate—GABRG2—brain—acquired immunodeficiency syndrome	0.000116	0.00244	CbGeAlD
Topiramate—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000115	0.00242	CbGeAlD
Topiramate—CA2—blood—acquired immunodeficiency syndrome	0.000114	0.0024	CbGeAlD
Topiramate—CA4—nervous system—acquired immunodeficiency syndrome	0.000112	0.00235	CbGeAlD
Topiramate—CA2—bone marrow—acquired immunodeficiency syndrome	0.00011	0.00232	CbGeAlD
Topiramate—CA2—spinal cord—acquired immunodeficiency syndrome	0.00011	0.00231	CbGeAlD
Topiramate—CA1—brain—acquired immunodeficiency syndrome	0.000109	0.00229	CbGeAlD
Topiramate—CA4—central nervous system—acquired immunodeficiency syndrome	0.000107	0.00226	CbGeAlD
Topiramate—CA2—vagina—acquired immunodeficiency syndrome	0.000106	0.00222	CbGeAlD
Topiramate—CA1—lymph node—acquired immunodeficiency syndrome	0.000105	0.00222	CbGeAlD
Topiramate—GABRA1—brain—acquired immunodeficiency syndrome	0.000103	0.00215	CbGeAlD
Topiramate—CA2—lung—acquired immunodeficiency syndrome	0.0001	0.0021	CbGeAlD
Topiramate—CA2—nervous system—acquired immunodeficiency syndrome	9.26e-05	0.00195	CbGeAlD
Topiramate—CA2—central nervous system—acquired immunodeficiency syndrome	8.91e-05	0.00187	CbGeAlD
Topiramate—CA4—brain—acquired immunodeficiency syndrome	8.53e-05	0.00179	CbGeAlD
Topiramate—CA4—lymph node—acquired immunodeficiency syndrome	8.24e-05	0.00173	CbGeAlD
Topiramate—CYP3A4—digestive system—acquired immunodeficiency syndrome	7.72e-05	0.00162	CbGeAlD
Topiramate—CYP3A4—blood—acquired immunodeficiency syndrome	7.36e-05	0.00155	CbGeAlD
Topiramate—CA2—brain—acquired immunodeficiency syndrome	7.08e-05	0.00149	CbGeAlD
Topiramate—CA2—lymph node—acquired immunodeficiency syndrome	6.84e-05	0.00144	CbGeAlD
Topiramate—CYP3A4—nervous system—acquired immunodeficiency syndrome	5.97e-05	0.00125	CbGeAlD
Topiramate—CYP3A4—central nervous system—acquired immunodeficiency syndrome	5.75e-05	0.00121	CbGeAlD
Topiramate—Anxiety—Ritonavir—acquired immunodeficiency syndrome	3.34e-05	0.000295	CcSEcCtD
Topiramate—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	3.33e-05	0.000294	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.33e-05	0.000294	CcSEcCtD
Topiramate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.32e-05	0.000293	CcSEcCtD
Topiramate—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.31e-05	0.000292	CcSEcCtD
Topiramate—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.31e-05	0.000292	CcSEcCtD
Topiramate—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.31e-05	0.000292	CcSEcCtD
Topiramate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.31e-05	0.000292	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.31e-05	0.000292	CcSEcCtD
Topiramate—Cough—Saquinavir—acquired immunodeficiency syndrome	3.31e-05	0.000292	CcSEcCtD
Topiramate—Pain—Indinavir—acquired immunodeficiency syndrome	3.29e-05	0.00029	CcSEcCtD
Topiramate—Constipation—Indinavir—acquired immunodeficiency syndrome	3.29e-05	0.00029	CcSEcCtD
Topiramate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.29e-05	0.00029	CcSEcCtD
Topiramate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.28e-05	0.00029	CcSEcCtD
Topiramate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	3.28e-05	0.000289	CcSEcCtD
Topiramate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	3.28e-05	0.000289	CcSEcCtD
Topiramate—Hypertension—Saquinavir—acquired immunodeficiency syndrome	3.27e-05	0.000288	CcSEcCtD
Topiramate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.27e-05	0.000288	CcSEcCtD
Topiramate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.27e-05	0.000288	CcSEcCtD
Topiramate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.26e-05	0.000288	CcSEcCtD
Topiramate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.26e-05	0.000288	CcSEcCtD
Topiramate—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.26e-05	0.000287	CcSEcCtD
Topiramate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.25e-05	0.000287	CcSEcCtD
Topiramate—Nausea—Didanosine—acquired immunodeficiency syndrome	3.25e-05	0.000287	CcSEcCtD
Topiramate—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.25e-05	0.000286	CcSEcCtD
Topiramate—Hypotension—Delavirdine—acquired immunodeficiency syndrome	3.25e-05	0.000286	CcSEcCtD
Topiramate—Syncope—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000286	CcSEcCtD
Topiramate—Confusional state—Ritonavir—acquired immunodeficiency syndrome	3.24e-05	0.000286	CcSEcCtD
Topiramate—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.24e-05	0.000285	CcSEcCtD
Topiramate—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.000285	CcSEcCtD
Topiramate—Somnolence—Efavirenz—acquired immunodeficiency syndrome	3.23e-05	0.000285	CcSEcCtD
Topiramate—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.23e-05	0.000284	CcSEcCtD
Topiramate—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.23e-05	0.000284	CcSEcCtD
Topiramate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	3.23e-05	0.000284	CcSEcCtD
Topiramate—Anxiety—Saquinavir—acquired immunodeficiency syndrome	3.22e-05	0.000283	CcSEcCtD
Topiramate—Oedema—Ritonavir—acquired immunodeficiency syndrome	3.21e-05	0.000283	CcSEcCtD
Topiramate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.21e-05	0.000283	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.2e-05	0.000283	CcSEcCtD
Topiramate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	3.2e-05	0.000282	CcSEcCtD
Topiramate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.19e-05	0.000281	CcSEcCtD
Topiramate—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	3.18e-05	0.00028	CcSEcCtD
Topiramate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.17e-05	0.000279	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.17e-05	0.000279	CcSEcCtD
Topiramate—Shock—Ritonavir—acquired immunodeficiency syndrome	3.16e-05	0.000279	CcSEcCtD
Topiramate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.16e-05	0.000278	CcSEcCtD
Topiramate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	3.16e-05	0.000278	CcSEcCtD
Topiramate—Cough—Lamivudine—acquired immunodeficiency syndrome	3.16e-05	0.000278	CcSEcCtD
Topiramate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.15e-05	0.000278	CcSEcCtD
Topiramate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.15e-05	0.000278	CcSEcCtD
Topiramate—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.15e-05	0.000277	CcSEcCtD
Topiramate—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.15e-05	0.000277	CcSEcCtD
Topiramate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.14e-05	0.000277	CcSEcCtD
Topiramate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.14e-05	0.000277	CcSEcCtD
Topiramate—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	3.14e-05	0.000277	CcSEcCtD
Topiramate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.14e-05	0.000276	CcSEcCtD
Topiramate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	3.13e-05	0.000276	CcSEcCtD
Topiramate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.13e-05	0.000276	CcSEcCtD
Topiramate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.13e-05	0.000276	CcSEcCtD
Topiramate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.12e-05	0.000275	CcSEcCtD
Topiramate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.12e-05	0.000275	CcSEcCtD
Topiramate—Confusional state—Saquinavir—acquired immunodeficiency syndrome	3.12e-05	0.000275	CcSEcCtD
Topiramate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	3.11e-05	0.000274	CcSEcCtD
Topiramate—Pain—Efavirenz—acquired immunodeficiency syndrome	3.11e-05	0.000274	CcSEcCtD
Topiramate—Constipation—Efavirenz—acquired immunodeficiency syndrome	3.11e-05	0.000274	CcSEcCtD
Topiramate—Rash—Nevirapine—acquired immunodeficiency syndrome	3.11e-05	0.000274	CcSEcCtD
Topiramate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.1e-05	0.000274	CcSEcCtD
Topiramate—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.1e-05	0.000273	CcSEcCtD
Topiramate—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.1e-05	0.000273	CcSEcCtD
Topiramate—Oedema—Saquinavir—acquired immunodeficiency syndrome	3.09e-05	0.000273	CcSEcCtD
Topiramate—Somnolence—Delavirdine—acquired immunodeficiency syndrome	3.09e-05	0.000272	CcSEcCtD
Topiramate—Headache—Nevirapine—acquired immunodeficiency syndrome	3.09e-05	0.000272	CcSEcCtD
Topiramate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	3.08e-05	0.000271	CcSEcCtD
Topiramate—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.08e-05	0.000271	CcSEcCtD
Topiramate—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.08e-05	0.000271	CcSEcCtD
Topiramate—Infection—Saquinavir—acquired immunodeficiency syndrome	3.07e-05	0.000271	CcSEcCtD
Topiramate—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.07e-05	0.00027	CcSEcCtD
Topiramate—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.06e-05	0.00027	CcSEcCtD
Topiramate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	3.06e-05	0.00027	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.00027	CcSEcCtD
Topiramate—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.05e-05	0.000269	CcSEcCtD
Topiramate—Shock—Saquinavir—acquired immunodeficiency syndrome	3.04e-05	0.000268	CcSEcCtD
Topiramate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.04e-05	0.000268	CcSEcCtD
Topiramate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.04e-05	0.000268	CcSEcCtD
Topiramate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.04e-05	0.000268	CcSEcCtD
Topiramate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.03e-05	0.000267	CcSEcCtD
Topiramate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.03e-05	0.000267	CcSEcCtD
Topiramate—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.03e-05	0.000267	CcSEcCtD
Topiramate—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.02e-05	0.000267	CcSEcCtD
Topiramate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.02e-05	0.000266	CcSEcCtD
Topiramate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	3.01e-05	0.000265	CcSEcCtD
Topiramate—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.01e-05	0.000265	CcSEcCtD
Topiramate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.01e-05	0.000265	CcSEcCtD
Topiramate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3e-05	0.000265	CcSEcCtD
Topiramate—Hypotension—Ritonavir—acquired immunodeficiency syndrome	3e-05	0.000265	CcSEcCtD
Topiramate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3e-05	0.000265	CcSEcCtD
Topiramate—Rash—Stavudine—acquired immunodeficiency syndrome	3e-05	0.000264	CcSEcCtD
Topiramate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3e-05	0.000264	CcSEcCtD
Topiramate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3e-05	0.000264	CcSEcCtD
Topiramate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	2.99e-05	0.000264	CcSEcCtD
Topiramate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	2.99e-05	0.000264	CcSEcCtD
Topiramate—Headache—Nelfinavir—acquired immunodeficiency syndrome	2.99e-05	0.000263	CcSEcCtD
Topiramate—Headache—Stavudine—acquired immunodeficiency syndrome	2.98e-05	0.000263	CcSEcCtD
Topiramate—Vomiting—Abacavir—acquired immunodeficiency syndrome	2.98e-05	0.000263	CcSEcCtD
Topiramate—Confusional state—Lamivudine—acquired immunodeficiency syndrome	2.98e-05	0.000262	CcSEcCtD
Topiramate—Constipation—Delavirdine—acquired immunodeficiency syndrome	2.97e-05	0.000262	CcSEcCtD
Topiramate—Pain—Delavirdine—acquired immunodeficiency syndrome	2.97e-05	0.000262	CcSEcCtD
Topiramate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	2.97e-05	0.000262	CcSEcCtD
Topiramate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	2.97e-05	0.000261	CcSEcCtD
Topiramate—Rash—Abacavir—acquired immunodeficiency syndrome	2.95e-05	0.00026	CcSEcCtD
Topiramate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	2.95e-05	0.00026	CcSEcCtD
Topiramate—Oedema—Lamivudine—acquired immunodeficiency syndrome	2.95e-05	0.00026	CcSEcCtD
Topiramate—Anorexia—Saquinavir—acquired immunodeficiency syndrome	2.95e-05	0.00026	CcSEcCtD
Topiramate—Headache—Abacavir—acquired immunodeficiency syndrome	2.94e-05	0.000259	CcSEcCtD
Topiramate—Infection—Lamivudine—acquired immunodeficiency syndrome	2.93e-05	0.000258	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	2.93e-05	0.000258	CcSEcCtD
Topiramate—Nausea—Nevirapine—acquired immunodeficiency syndrome	2.93e-05	0.000258	CcSEcCtD
Topiramate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	2.92e-05	0.000258	CcSEcCtD
Topiramate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	2.91e-05	0.000256	CcSEcCtD
Topiramate—Shock—Lamivudine—acquired immunodeficiency syndrome	2.9e-05	0.000256	CcSEcCtD
Topiramate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	2.89e-05	0.000255	CcSEcCtD
Topiramate—Hypotension—Saquinavir—acquired immunodeficiency syndrome	2.89e-05	0.000255	CcSEcCtD
Topiramate—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	2.89e-05	0.000255	CcSEcCtD
Topiramate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	2.89e-05	0.000254	CcSEcCtD
Topiramate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	2.89e-05	0.000254	CcSEcCtD
Topiramate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.87e-05	0.000253	CcSEcCtD
Topiramate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	2.87e-05	0.000253	CcSEcCtD
Topiramate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000253	CcSEcCtD
Topiramate—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	2.87e-05	0.000253	CcSEcCtD
Topiramate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	2.86e-05	0.000252	CcSEcCtD
Topiramate—Somnolence—Ritonavir—acquired immunodeficiency syndrome	2.86e-05	0.000252	CcSEcCtD
Topiramate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	2.85e-05	0.000251	CcSEcCtD
Topiramate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.84e-05	0.000251	CcSEcCtD
Topiramate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.83e-05	0.00025	CcSEcCtD
Topiramate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.83e-05	0.00025	CcSEcCtD
Topiramate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	2.83e-05	0.000249	CcSEcCtD
Topiramate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.83e-05	0.000249	CcSEcCtD
Topiramate—Nausea—Stavudine—acquired immunodeficiency syndrome	2.83e-05	0.000249	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.82e-05	0.000248	CcSEcCtD
Topiramate—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.81e-05	0.000248	CcSEcCtD
Topiramate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	2.8e-05	0.000247	CcSEcCtD
Topiramate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.79e-05	0.000246	CcSEcCtD
Topiramate—Nausea—Abacavir—acquired immunodeficiency syndrome	2.78e-05	0.000245	CcSEcCtD
Topiramate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	2.78e-05	0.000245	CcSEcCtD
Topiramate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	2.77e-05	0.000245	CcSEcCtD
Topiramate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	2.77e-05	0.000244	CcSEcCtD
Topiramate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	2.76e-05	0.000243	CcSEcCtD
Topiramate—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.76e-05	0.000243	CcSEcCtD
Topiramate—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	2.76e-05	0.000243	CcSEcCtD
Topiramate—Hypotension—Lamivudine—acquired immunodeficiency syndrome	2.76e-05	0.000243	CcSEcCtD
Topiramate—Somnolence—Saquinavir—acquired immunodeficiency syndrome	2.75e-05	0.000242	CcSEcCtD
Topiramate—Pain—Ritonavir—acquired immunodeficiency syndrome	2.75e-05	0.000242	CcSEcCtD
Topiramate—Constipation—Ritonavir—acquired immunodeficiency syndrome	2.75e-05	0.000242	CcSEcCtD
Topiramate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	2.75e-05	0.000242	CcSEcCtD
Topiramate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.75e-05	0.000242	CcSEcCtD
Topiramate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	2.73e-05	0.000241	CcSEcCtD
Topiramate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	2.72e-05	0.00024	CcSEcCtD
Topiramate—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.72e-05	0.00024	CcSEcCtD
Topiramate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.69e-05	0.000237	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.69e-05	0.000237	CcSEcCtD
Topiramate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.68e-05	0.000236	CcSEcCtD
Topiramate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.67e-05	0.000235	CcSEcCtD
Topiramate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	2.67e-05	0.000235	CcSEcCtD
Topiramate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.67e-05	0.000235	CcSEcCtD
Topiramate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.65e-05	0.000234	CcSEcCtD
Topiramate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.65e-05	0.000233	CcSEcCtD
Topiramate—Pain—Saquinavir—acquired immunodeficiency syndrome	2.65e-05	0.000233	CcSEcCtD
Topiramate—Constipation—Saquinavir—acquired immunodeficiency syndrome	2.65e-05	0.000233	CcSEcCtD
Topiramate—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	2.63e-05	0.000232	CcSEcCtD
Topiramate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.63e-05	0.000232	CcSEcCtD
Topiramate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.63e-05	0.000232	CcSEcCtD
Topiramate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.63e-05	0.000232	CcSEcCtD
Topiramate—Somnolence—Lamivudine—acquired immunodeficiency syndrome	2.62e-05	0.000231	CcSEcCtD
Topiramate—Rash—Zidovudine—acquired immunodeficiency syndrome	2.61e-05	0.00023	CcSEcCtD
Topiramate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.61e-05	0.00023	CcSEcCtD
Topiramate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.6e-05	0.00023	CcSEcCtD
Topiramate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	2.6e-05	0.000229	CcSEcCtD
Topiramate—Headache—Zidovudine—acquired immunodeficiency syndrome	2.59e-05	0.000228	CcSEcCtD
Topiramate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.57e-05	0.000227	CcSEcCtD
Topiramate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.57e-05	0.000226	CcSEcCtD
Topiramate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.56e-05	0.000226	CcSEcCtD
Topiramate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	2.55e-05	0.000225	CcSEcCtD
Topiramate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.55e-05	0.000225	CcSEcCtD
Topiramate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.55e-05	0.000225	CcSEcCtD
Topiramate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.54e-05	0.000224	CcSEcCtD
Topiramate—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.54e-05	0.000224	CcSEcCtD
Topiramate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.54e-05	0.000224	CcSEcCtD
Topiramate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.54e-05	0.000224	CcSEcCtD
Topiramate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.53e-05	0.000223	CcSEcCtD
Topiramate—Pain—Lamivudine—acquired immunodeficiency syndrome	2.52e-05	0.000222	CcSEcCtD
Topiramate—Constipation—Lamivudine—acquired immunodeficiency syndrome	2.52e-05	0.000222	CcSEcCtD
Topiramate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.49e-05	0.00022	CcSEcCtD
Topiramate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.49e-05	0.000219	CcSEcCtD
Topiramate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.46e-05	0.000217	CcSEcCtD
Topiramate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.46e-05	0.000217	CcSEcCtD
Topiramate—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.46e-05	0.000216	CcSEcCtD
Topiramate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.45e-05	0.000216	CcSEcCtD
Topiramate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.45e-05	0.000216	CcSEcCtD
Topiramate—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.44e-05	0.000215	CcSEcCtD
Topiramate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.43e-05	0.000214	CcSEcCtD
Topiramate—Rash—Indinavir—acquired immunodeficiency syndrome	2.42e-05	0.000214	CcSEcCtD
Topiramate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.42e-05	0.000213	CcSEcCtD
Topiramate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.41e-05	0.000213	CcSEcCtD
Topiramate—Headache—Indinavir—acquired immunodeficiency syndrome	2.41e-05	0.000212	CcSEcCtD
Topiramate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.4e-05	0.000212	CcSEcCtD
Topiramate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.38e-05	0.00021	CcSEcCtD
Topiramate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.37e-05	0.000209	CcSEcCtD
Topiramate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.34e-05	0.000207	CcSEcCtD
Topiramate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.33e-05	0.000206	CcSEcCtD
Topiramate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.33e-05	0.000206	CcSEcCtD
Topiramate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.31e-05	0.000204	CcSEcCtD
Topiramate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.31e-05	0.000203	CcSEcCtD
Topiramate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.3e-05	0.000203	CcSEcCtD
Topiramate—Rash—Efavirenz—acquired immunodeficiency syndrome	2.29e-05	0.000202	CcSEcCtD
Topiramate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.29e-05	0.000202	CcSEcCtD
Topiramate—Nausea—Indinavir—acquired immunodeficiency syndrome	2.28e-05	0.000201	CcSEcCtD
Topiramate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.28e-05	0.000201	CcSEcCtD
Topiramate—Headache—Efavirenz—acquired immunodeficiency syndrome	2.28e-05	0.000201	CcSEcCtD
Topiramate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.27e-05	0.0002	CcSEcCtD
Topiramate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.22e-05	0.000196	CcSEcCtD
Topiramate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.21e-05	0.000195	CcSEcCtD
Topiramate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.2e-05	0.000194	CcSEcCtD
Topiramate—Rash—Delavirdine—acquired immunodeficiency syndrome	2.19e-05	0.000193	CcSEcCtD
Topiramate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.19e-05	0.000193	CcSEcCtD
Topiramate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.19e-05	0.000193	CcSEcCtD
Topiramate—Headache—Delavirdine—acquired immunodeficiency syndrome	2.18e-05	0.000192	CcSEcCtD
Topiramate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.17e-05	0.000192	CcSEcCtD
Topiramate—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.16e-05	0.00019	CcSEcCtD
Topiramate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.13e-05	0.000187	CcSEcCtD
Topiramate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.12e-05	0.000187	CcSEcCtD
Topiramate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.12e-05	0.000187	CcSEcCtD
Topiramate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.09e-05	0.000184	CcSEcCtD
Topiramate—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.06e-05	0.000182	CcSEcCtD
Topiramate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.05e-05	0.00018	CcSEcCtD
Topiramate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.04e-05	0.00018	CcSEcCtD
Topiramate—Rash—Ritonavir—acquired immunodeficiency syndrome	2.03e-05	0.000179	CcSEcCtD
Topiramate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.02e-05	0.000178	CcSEcCtD
Topiramate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.02e-05	0.000178	CcSEcCtD
Topiramate—Headache—Ritonavir—acquired immunodeficiency syndrome	2.01e-05	0.000177	CcSEcCtD
Topiramate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	1.97e-05	0.000173	CcSEcCtD
Topiramate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	1.95e-05	0.000172	CcSEcCtD
Topiramate—Rash—Saquinavir—acquired immunodeficiency syndrome	1.95e-05	0.000172	CcSEcCtD
Topiramate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	1.95e-05	0.000172	CcSEcCtD
Topiramate—Headache—Saquinavir—acquired immunodeficiency syndrome	1.94e-05	0.000171	CcSEcCtD
Topiramate—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.91e-05	0.000168	CcSEcCtD
Topiramate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.88e-05	0.000165	CcSEcCtD
Topiramate—Rash—Lamivudine—acquired immunodeficiency syndrome	1.86e-05	0.000164	CcSEcCtD
Topiramate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.86e-05	0.000164	CcSEcCtD
Topiramate—Headache—Lamivudine—acquired immunodeficiency syndrome	1.85e-05	0.000163	CcSEcCtD
Topiramate—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.84e-05	0.000162	CcSEcCtD
Topiramate—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.75e-05	0.000155	CcSEcCtD
